Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	choline-phosphate cytidylyltransferase activity	PCYT1A PCYT1B	8.26e-05	2	182	2	GO:0004105
GeneOntologyMolecularFunction	cytidylyltransferase activity	PCYT1A PCYT2 PCYT1B	8.53e-05	10	182	3	GO:0070567
GeneOntologyMolecularFunction	glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity	CSGALNACT2 CSGALNACT1	2.46e-04	3	182	2	GO:0047237
GeneOntologyMolecularFunction	microtubule minus-end binding	TUBGCP6 TUBGCP3 CAMSAP1	3.13e-04	15	182	3	GO:0051011
GeneOntologyMolecularFunction	phosphatase activity	INPP5D INPPL1 DUSP2 PPP1R3C DUSP26 NT5DC2 TIMM50 ACP4 SSH2 PLPPR2	3.14e-04	287	182	10	GO:0016791
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	PCYT1A PGS1 TEX14 LMTK3 ZAP70 MAP3K5 ITPKA SGK3 PHKG1 PARP1 LATS2 MTOR GYS2 PRKACA PRKACB PCYT2 PRKCB PRKCI NME1 PCYT1B	3.69e-04	938	182	20	GO:0016772
GeneOntologyMolecularFunction	gamma-tubulin binding	GIT1 TUBGCP6 TUBGCP3 NME1	3.87e-04	38	182	4	GO:0043015
GeneOntologyBiologicalProcess	polysaccharide biosynthetic process	GBE1 GFPT1 PPP1R3C PHKG1 CSGALNACT2 MTOR GYS2 CSGALNACT1	2.88e-07	76	177	8	GO:0000271
GeneOntologyBiologicalProcess	polysaccharide metabolic process	ATG2B GBE1 GFPT1 PPP1R3C PHKG1 CSGALNACT2 MTOR GYS2 CSGALNACT1	1.43e-06	126	177	9	GO:0005976
GeneOntologyBiologicalProcess	glycogen biosynthetic process	GBE1 GFPT1 PPP1R3C PHKG1 MTOR GYS2	7.50e-06	55	177	6	GO:0005978
GeneOntologyBiologicalProcess	glucan biosynthetic process	GBE1 GFPT1 PPP1R3C PHKG1 MTOR GYS2	7.50e-06	55	177	6	GO:0009250
GeneOntologyBiologicalProcess	carbohydrate biosynthetic process	GBE1 GFPT1 PPP1R3C PHKG1 PARP1 CSGALNACT2 MTOR GYS2 PRKACA FUT4 CSGALNACT1	9.88e-06	247	177	11	GO:0016051
GeneOntologyBiologicalProcess	glycogen metabolic process	ATG2B GBE1 GFPT1 PPP1R3C PHKG1 MTOR GYS2	2.33e-05	99	177	7	GO:0005977
GeneOntologyBiologicalProcess	glucan metabolic process	ATG2B GBE1 GFPT1 PPP1R3C PHKG1 MTOR GYS2	2.66e-05	101	177	7	GO:0044042
GeneOntologyBiologicalProcess	carbohydrate metabolic process	GIT1 GLB1L INPPL1 ATG2B GBE1 GFPT1 PPP1R3C PHKG1 PARP1 CSGALNACT2 MTOR NISCH GYS2 PRKACA FUT4 CSGALNACT1 OTOG	4.34e-05	646	177	17	GO:0005975
GeneOntologyBiologicalProcess	energy reserve metabolic process	ATG2B GBE1 GFPT1 PPP1R3C PHKG1 MTOR GYS2	5.79e-05	114	177	7	GO:0006112
GeneOntologyBiologicalProcess	chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	CSGALNACT2 CSGALNACT1	7.32e-05	2	177	2	GO:0050653
GeneOntologyCellularComponent	cell projection membrane	AMN MYO10 ADGRV1 SLC7A11 KCNB1 CSPG4 PKD1 CNTNAP2 PRKCB SGCE NME1 MTMR9	3.92e-04	431	181	12	GO:0031253
GeneOntologyCellularComponent	apical part of cell	SLC12A6 SLC4A7 AMN DNAAF11 SLC29A2 SLC7A11 KCNB1 LMO7 CSPG4 DCHS1 LRP1 PRKCI ABCG5 OTOG	6.68e-04	592	181	14	GO:0045177
GeneOntologyCellularComponent	protein kinase complex	ERCC2 MAP3K5 PHKG1 PRKACA PRKACB PRKCI MMS19	7.14e-04	170	181	7	GO:1902911
GeneOntologyCellularComponent	equatorial microtubule organizing center	TUBGCP6 TUBGCP3	7.33e-04	5	181	2	GO:0000923
GeneOntologyCellularComponent	MMXD complex	ERCC2 MMS19	7.33e-04	5	181	2	GO:0071817
GeneOntologyCellularComponent	polar microtubule	KLHL21 TUBGCP3	7.33e-04	5	181	2	GO:0005827
GeneOntologyCellularComponent	actin-based cell projection	SLC4A7 AMN MYO10 INPPL1 ADGRV1 SLC7A11 PKHD1L1 AOC3 DYNC1H1	7.34e-04	278	181	9	GO:0098858
GeneOntologyCellularComponent	cluster of actin-based cell projections	SLC4A7 AMN ADGRV1 SLC7A11 PKHD1L1 CLIC1 PRKCB PRKCI	7.46e-04	223	181	8	GO:0098862
Domain	AGC-kinase_C	SGK3 LATS2 PRKACA PRKACB PRKCB PRKCI	1.71e-05	56	182	6	IPR000961
Domain	AGC_KINASE_CTER	SGK3 LATS2 PRKACA PRKACB PRKCB PRKCI	1.71e-05	56	182	6	PS51285
Domain	S_TK_X	SGK3 LATS2 PRKACA PRKACB PRKCB PRKCI	1.71e-05	56	182	6	SM00133
Domain	CTP_transf_like	PCYT1A PCYT2 PCYT1B	3.10e-05	7	182	3	PF01467
Domain	Cyt_trans-like	PCYT1A PCYT2 PCYT1B	3.10e-05	7	182	3	IPR004821
Domain	Pkinase_C	SGK3 LATS2 PRKACA PRKCB PRKCI	5.28e-05	42	182	5	PF00433
Domain	Ig_E-set	PLXNA3 GBE1 PKHD1L1 NFATC3 KCNJ5 TGM7 PLXNB1	7.13e-05	104	182	7	IPR014756
Domain	DUF5050	LRP1B LRP1	9.44e-05	2	182	2	IPR032485
Domain	DUF5050	LRP1B LRP1	9.44e-05	2	182	2	PF16472
Domain	IPT	PLXNA3 PKHD1L1 NFATC3 PLXNB1	1.28e-04	27	182	4	SM00429
Domain	TIG	PLXNA3 PKHD1L1 NFATC3 PLXNB1	2.23e-04	31	182	4	PF01833
Domain	IPT	PLXNA3 PKHD1L1 NFATC3 PLXNB1	2.53e-04	32	182	4	IPR002909
Domain	Plexin_repeat	PLXNA3 PLXDC2 SEMA5B PLXNB1	2.53e-04	32	182	4	IPR002165
Domain	PSI	PLXNA3 PLXDC2 SEMA5B PLXNB1	2.53e-04	32	182	4	PF01437
Domain	Pkinase_C	SGK3 LATS2 PRKCB PRKCI	4.48e-04	37	182	4	IPR017892
Pathway	WP_HIPPO_SIGNALING_REGULATION	TEAD2 LATS2 MTOR PRKACA PRKACB PRKCB PRKCI	6.39e-05	98	144	7	M39830
Pathway	KEGG_INSULIN_SIGNALING_PATHWAY	INPP5D PPP1R3C PHKG1 MTOR GYS2 PRKACA PRKACB PRKCI	8.04e-05	137	144	8	M18155
Pathway	REACTOME_GLYCOGEN_METABOLISM	GBE1 PPP1R3C PHKG1 GYS2	1.12e-04	25	144	4	M27857
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	GLB1L GBE1 PPP1R3C PHKG1 CSGALNACT2 GYS2 CSPG4 PRKACA PRKACB FUT4 CSGALNACT1	1.80e-04	288	144	11	M16864
Pathway	WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS	PCYT1A MAT1A BHMT PCYT2 PCYT1B	2.19e-04	54	144	5	MM15848
Pathway	PID_CDC42_REG_PATHWAY	GIT1 FARP2 ARHGAP1 NME1	2.33e-04	30	144	4	M83
Pathway	REACTOME_RHOJ_GTPASE_CYCLE	SLC4A7 GIT1 WWP2 TFRC ARHGAP1	2.39e-04	55	144	5	M41815
Pathway	REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY	ERCC2 NDOR1 MMS19	2.77e-04	13	144	3	M27193
Pathway	REACTOME_RHOQ_GTPASE_CYCLE	SLC4A7 GIT1 WWP2 TFRC ARHGAP1	3.08e-04	58	144	5	MM15602
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	PCYT1A PGS1 INPP5D INPPL1 PCYT2 PNPLA7 MTMR9 GNPAT PCYT1B	3.16e-04	211	144	9	M649
Pathway	REACTOME_RHOQ_GTPASE_CYCLE	SLC4A7 GIT1 WWP2 TFRC ARHGAP1	3.33e-04	59	144	5	M41812
Pathway	WP_KENNEDY_PATHWAY	PCYT1A PCYT2 PCYT1B	3.50e-04	14	144	3	MM15980
Pathway	WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS	PCYT1A PCYT2 PCYT1B	3.50e-04	14	144	3	M39620
Pathway	REACTOME_GLYCOGEN_SYNTHESIS	GBE1 PPP1R3C GYS2	3.50e-04	14	144	3	M27247
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PLXNA3 TEAD2 ERCC2 NDOR1 MYO10 INPPL1 MED14 SLCO4A1 POMGNT1 FYCO1 HUWE1 NCLN SLC29A2 MAP3K5 BAP1 ZCCHC14 LATS2 POMGNT2 CELSR2 MTOR KLHL21 NISCH TTLL4 CSPG4 TMEM132A PKD1 PCYT2 CAMSAP1 DYNC1H1 EVI5L	1.98e-13	1105	184	30	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KCTD9 GIT1 FYCO1 HUWE1 LMTK3 MAP3K5 PARP1 UBE2O CELSR2 KCNB1 NFATC3 MTOR NISCH PRKACA PRKACB DCHS1 LRP1 PRKCB PRKCI SSH2 FRMPD3 CAMSAP1 MGA DYNC1H1	3.57e-10	963	184	24	28671696
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PLXNA3 KCTD9 DUSP2 CAPN3 LRP1B GFPT1 BAP1 SGK3 LATS2 KCNB1 PRKACA PRKACB LRP1 PRKCB PRKCI TGM7 SSH2 FUT4 KLHL18 TARS1 MTMR9	3.86e-10	730	184	21	34857952
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	TFRC PARP1 CELSR2 TIMM50 DCHS1 ITM2C DYNC1H1	6.88e-08	67	184	7	21875946
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PLXNA3 FAM234A POMGNT1 NCLN SLC7A11 LRP1B TFRC POMGNT2 CSGALNACT2 CELSR2 CLIC1 FDFT1 SEC62 CSPG4 TMEM132A LRP1 SGCE ITM2C NME1 CSGALNACT1 PLXNB1 AMIGO2	4.52e-07	1201	184	22	35696571
Pubmed	GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor.	MTOR PRKACA PRKACB	5.80e-07	4	184	3	31112131
Pubmed	Cloning of a mouse protein kinase A catalytic subunit pseudogene and chromosomal mapping of C subunit isoforms.	PRKACA PRKACB PRKCB	5.80e-07	4	184	3	7873880
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SLC4A7 GIT1 ATG2B RPL14 HUWE1 NCLN LRP1B SFXN5 UBE2O POMGNT2 CELSR2 KCNB1 SEC62 CNTNAP2 TIMM50 PRKCB ITM2C NME1 CAMSAP1 PLPPR2 VCPIP1	7.59e-07	1139	184	21	36417873
Pubmed	Liver and brain differential expression of one-carbon metabolism genes during ontogenesis.	PCYT1A MAT1A BHMT PCYT2 PCYT1B	8.26e-07	33	184	5	34702858
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLC4A7 GIT1 MYO9A WWP2 INPPL1 DENND4C ZCCHC14 VPS13D NFATC3 LMO7 MTOR SAMD11 TIMM50 PRKCI SSH2 CAMSAP1 OTOG VCPIP1	8.49e-07	861	184	18	36931259
Pubmed	Defining the membrane proteome of NK cells.	GIT1 WWP2 CYP20A1 MED14 RABAC1 FYCO1 RPL14 HUWE1 NCLN TUBGCP6 PARP1 CSGALNACT2 CLIC1 MTOR NISCH TUBGCP3 MMS19 NME1 HECA DYNC1H1 GNPAT	1.13e-06	1168	184	21	19946888
Pubmed	Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.	PRKACA PRKACB PRKCB	1.45e-06	5	184	3	19573263
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	SLC4A7 SLCO4A1 SLC29A2 SLC7A11 TFRC FARP2 LATS2 CELSR2 MTOR CSPG4 CAMSAP1 PCDH18 PLXNB1 AMIGO2	2.33e-06	569	184	14	30639242
Pubmed	Network organization of the human autophagy system.	BTBD8 ATG2B FYCO1 MON1B GFPT1 MAP3K5 PARP1 MTOR PRKCI MRPL38 RASSF4 TARS1	4.16e-06	437	184	12	20562859
Pubmed	The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains.	PRKACA PRKACB PRKCB PRKCI	4.23e-06	21	184	4	22114277
Pubmed	Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways.	PRKACA PRKACB PRKCB PRKCI	4.23e-06	21	184	4	9671211
Pubmed	The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.	PRKACA PRKACB PRKCB PRKCI	5.15e-06	22	184	4	9151826
Pubmed	A novel missense variant in CUL3 shows altered binding ability to BTB-adaptor proteins leading to diverse phenotypes of CUL3-related disorders.	KCTD9 KLHL21 KLHL15 KLHL18	6.21e-06	23	184	4	33130828
Pubmed	A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development.	KCTD9 GIT1 VPS13D KLHL21 KLHL15 KLHL18	7.15e-06	87	184	6	37495603
Pubmed	Glycogen synthase kinase-3: properties, functions, and regulation.	SGK3 PRKACA PRKCB	8.00e-06	8	184	3	11749387
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SLC4A7 CYP20A1 POMGNT1 GBE1 CP RPL14 NCLN LCMT2 GFPT1 TFRC CSGALNACT2 CELSR2 NT5DC2 SEC62 CSPG4 TIMM50 LRP1 ITM2C PNPLA7 NME1 CSGALNACT1 VCPIP1	9.58e-06	1451	184	22	30550785
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	CP TFRC PLXDC2 CSPG4 AOC3 LRP1 C8B SERPIND1 PLXNB1	1.01e-05	257	184	9	16335952
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	ERCC2 MYO10 INPPL1 FYCO1 DENND4C FARP2 ARHGAP1 MTOR TTLL4 TUBGCP3 PRKACA PRKACB PRKCI SSH2 SNAPC3 MTMR9 EVI5L GNPAT	1.13e-05	1038	184	18	26673895
Pubmed	Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction.	SGK3 PRKACA PRKCB	1.20e-05	9	184	3	12054501
Pubmed	Role of phosphorylation in the nuclear biology of HIV-1.	PRKACA PRKACB PRKCB PRKCI	1.21e-05	27	184	4	21651489
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SLC4A7 RRP1B WWP2 RPL14 NCLN LCMT2 TFRC TUBGCP6 ARHGAP1 PARP1 UBE2O FDFT1 NT5DC2 NISCH TUBGCP3 PRKACA PRKACB TIMM50 PRKCI MRPL38 ITM2C TARS1	1.40e-05	1487	184	22	33957083
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MYO9A INPPL1 ATG2B DENND4C VPS13D UBE2O CAMSAP1 VCPIP1	1.68e-05	209	184	8	36779422
Pubmed	Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.	SGK3 PRKACA PRKCB	1.70e-05	10	184	3	11884598
Pubmed	Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.	SGK3 PRKACA PRKCB	1.70e-05	10	184	3	11035810
Pubmed	Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.	STAG1 CCDC92 CELSR2 ABCG5	1.87e-05	30	184	4	19936222
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	TUBGCP6 PARP1 TUBGCP3 PRKACA PRKACB	2.15e-05	63	184	5	29162697
Pubmed	Phosphorylation of tau is regulated by PKN.	PRKACA PRKCB PRKCI	2.33e-05	11	184	3	11104762
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GIT1 RRP1B MED14 FYCO1 HUWE1 GFPT1 PARP1 NISCH MMS19 CAMSAP1 THAP12	2.51e-05	440	184	11	34244565
Pubmed	Protein kinase Cbeta is an effective target for chemoprevention of colon cancer.	PRKACB PRKCB	2.78e-05	2	184	2	19221092
Pubmed	Distribution of CTP:phosphocholine cytidylyltransferase (CCT) isoforms. Identification of a new CCTbeta splice variant.	PCYT1A PCYT1B	2.78e-05	2	184	2	10480912
Pubmed	Striking differences of LDL receptor-related protein 1B expression in mouse and human.	LRP1B LRP1	2.78e-05	2	184	2	15963947
Pubmed	Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.	PARP1 MTOR	2.78e-05	2	184	2	27055253
Pubmed	Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?	MTOR PKD1	2.78e-05	2	184	2	17102641
Pubmed	Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB	2.78e-05	2	184	2	3023318
Pubmed	Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: implication for receptor-mediated endocytosis.	PRKACA LRP1	2.78e-05	2	184	2	11158305
Pubmed	Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2.	INPP5D INPPL1	2.78e-05	2	184	2	38309262
Pubmed	PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent.	PARP1 MTOR	2.78e-05	2	184	2	23110147
Pubmed	NFATc3 regulates Kv2.1 expression in arterial smooth muscle.	KCNB1 NFATC3	2.78e-05	2	184	2	15322114
Pubmed	Histone H3 lysine 4 methylation signature associated with human undernutrition.	NDOR1 LRP1	2.78e-05	2	184	2	30420518
Pubmed	Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.	ZAP70 PRKCB	2.78e-05	2	184	2	19907441
Pubmed	mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors.	PARP1 MTOR	2.78e-05	2	184	2	32066462
Pubmed	Alterations in the chondroitin sulfate chain in human osteoarthritic cartilage of the knee.	CSGALNACT2 CSGALNACT1	2.78e-05	2	184	2	24280246
Pubmed	Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling.	WWP2 PARP1	2.78e-05	2	184	2	32139900
Pubmed	Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1.	DFFB PARP1	2.78e-05	2	184	2	15703174
Pubmed	Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.	PRKACA PRKACB	2.78e-05	2	184	2	36152045
Pubmed	PRKACA/PRKACB Fusions in Pancreatobiliary Intraductal Oncocytic Papillary Neoplasms Including Those With Atypical Morphology: An Analysis of 22 Cases Expanding Morphologic Spectrum.	PRKACA PRKACB	2.78e-05	2	184	2	38841868
Pubmed	Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.	DOK7 GFPT1	2.78e-05	2	184	2	21975507
Pubmed	Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).	MTOR PRKCI	2.78e-05	2	184	2	21373201
Pubmed	Molecular cloning and expression of human chondroitin N-acetylgalactosaminyltransferase: the key enzyme for chain initiation and elongation of chondroitin/dermatan sulfate on the protein linkage region tetrasaccharide shared by heparin/heparan sulfate.	CSGALNACT2 CSGALNACT1	2.78e-05	2	184	2	11788602
Pubmed	Molecular and behavioral effects of a null mutation in all PKA C beta isoforms.	PRKACA PRKACB	2.78e-05	2	184	2	12139926
Pubmed	The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics.	INPP5D INPPL1	2.78e-05	2	184	2	19839650
Pubmed	Protein kinase C iota promotes glycolysis via PI3K/AKT/mTOR signalling in high grade serous ovarian cancer.	MTOR PRKCI	2.78e-05	2	184	2	39276277
Pubmed	Characterization of genomic clones coding for the C alpha and C beta subunits of mouse cAMP-dependent protein kinase.	PRKACA PRKACB	2.78e-05	2	184	2	2833513
Pubmed	Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.	CSGALNACT2 CSGALNACT1	2.78e-05	2	184	2	19298595
Pubmed	A catalogue of genes in the cardiovascular system as identified by expressed sequence tags.	CLIC1 ITM2C	2.78e-05	2	184	2	7938007
Pubmed	SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.	INPP5D INPPL1	2.78e-05	2	184	2	12885297
Pubmed	Global consequences of activation loop phosphorylation on protein kinase A.	PRKACA PRKACB	2.78e-05	2	184	2	19965870
Pubmed	Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis.	PRKACA PRKACB	2.78e-05	2	184	2	12180908
Pubmed	Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.	PRKACA PRKACB	2.78e-05	2	184	2	31678302
Pubmed	Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.	ZAP70 PRKCB	2.78e-05	2	184	2	17926183
Pubmed	Systems-level identification of PKA-dependent signaling in epithelial cells.	PRKACA PRKACB	2.78e-05	2	184	2	28973931
Pubmed	The role of E3 ubiquitin ligase WWP2 and the regulation of PARP1 by ubiquitinated degradation in acute lymphoblastic leukemia.	WWP2 PARP1	2.78e-05	2	184	2	36257929
Pubmed	LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.	PARP1 LRP1	2.78e-05	2	184	2	26634655
Pubmed	Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.	PRKACA PRKACB	2.78e-05	2	184	2	37871652
Pubmed	Differential roles of two N-acetylgalactosaminyltransferases, CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2. Initiation and elongation in synthesis of chondroitin sulfate.	CSGALNACT2 CSGALNACT1	2.78e-05	2	184	2	12446672
Pubmed	Two novel brain-specific splice variants of the murine Cbeta gene of cAMP-dependent protein kinase.	PRKACB PRKCB	2.78e-05	2	184	2	9368018
Pubmed	Differential dephosphorylation of CTP:phosphocholine cytidylyltransferase upon translocation to nuclear membranes and lipid droplets.	PCYT1A PCYT1B	2.78e-05	2	184	2	32186954
Pubmed	CTP:phosphocholine cytidylyltransferase: Function, regulation, and structure of an amphitropic enzyme required for membrane biogenesis.	PCYT1A PCYT1B	2.78e-05	2	184	2	26165797
Pubmed	Gene structure, expression and identification of a new CTP:phosphocholine cytidylyltransferase beta isoform.	PCYT1A PCYT1B	2.78e-05	2	184	2	12842190
Pubmed	Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway.	PRKCB PRKCI	2.78e-05	2	184	2	15037605
Pubmed	Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.	TFRC MTOR	2.78e-05	2	184	2	37982952
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	KCTD9 FAM234A HUWE1 NCLN GFPT1 TFRC UBE2O MTOR FDFT1 NISCH SEC62 MMS19 ITM2C TARS1 DYNC1H1 VCPIP1	4.51e-05	942	184	16	31073040
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TEAD2 SLC4A7 STAG1 HUWE1 BAP1 POMGNT2 NFIC NISCH LRP1 MMS19 MRPL38 NME1 CAMSAP1 MGA DYNC1H1	5.62e-05	857	184	15	25609649
Pubmed	Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.	RABAC1 RPL14 HUWE1 GFPT1 ARHGAP1 HSD17B6 AOC3 PCDH18	5.84e-05	249	184	8	30097533
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	FAM234A SLC4A7 RRP1B CYP20A1 RPL14 NCLN SLC7A11 TFRC PARP1 FDFT1 SEC62 CSPG4 TMEM132A LRP1 MGA THAP12 GNPAT AMIGO2	7.67e-05	1203	184	18	29180619
Pubmed	Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines.	MTOR PKD1	8.32e-05	3	184	2	31251475
Pubmed	Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury.	CSGALNACT2 CSGALNACT1	8.32e-05	3	184	2	24220492
Pubmed	Protein kinase C betaII and PKCiota/lambda: collaborating partners in colon cancer promotion and progression.	PRKCB PRKCI	8.32e-05	3	184	2	19147581
Pubmed	Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice.	MTOR CNTNAP2	8.32e-05	3	184	2	31874168
Pubmed	NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells.	CSPG4 AOC3	8.32e-05	3	184	2	33727640
Pubmed	Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB	8.32e-05	3	184	2	2342480
Pubmed	Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study.	ERCC2 PARP1	8.32e-05	3	184	2	20559012
Pubmed	Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.	NDOR1 MTOR	8.32e-05	3	184	2	25059582
Pubmed	PARP1 orchestrates variant histone exchange in signal-mediated transcriptional activation.	PARP1 NFIC	8.32e-05	3	184	2	24145797
Pubmed	Role of WW domain E3 ubiquitin protein ligase 2 in modulating ubiquitination and Degradation of Septin4 in oxidative stress endothelial injury.	WWP2 PARP1	8.32e-05	3	184	2	31924572
Pubmed	SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase.	INPP5D INPPL1	8.32e-05	3	184	2	15492005
Pubmed	Specific protein kinase C isoforms α and βI are involved in follicle-stimulating hormone-induced mouse follicle-enclosed oocytes meiotic resumption.	PRKACA PRKCB	8.32e-05	3	184	2	23028752
Pubmed	A genetic test of the effects of mutations in PKA on mossy fiber LTP and its relation to spatial and contextual learning.	PRKACA PRKACB	8.32e-05	3	184	2	8548807
Pubmed	GlcUAβ1-3Galβ1-3Galβ1-4Xyl(2-O-phosphate) is the preferred substrate for chondroitin N-acetylgalactosaminyltransferase-1.	CSGALNACT2 CSGALNACT1	8.32e-05	3	184	2	25568321
Pubmed	Kinetic evidence that Glut4 follows different endocytic pathways than the receptors for transferrin and alpha2-macroglobulin.	TFRC LRP1	8.32e-05	3	184	2	21252237
Pubmed	Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.	INPP5D INPPL1	8.32e-05	3	184	2	31836657
Pubmed	Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly(ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized endonuclease that translocates to the nucleus during apoptosis.	DFFB PARP1	8.32e-05	3	184	2	23229555
Pubmed	mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex.	MTOR PKD1	8.32e-05	3	184	2	26931735
Pubmed	Sec14 homology domain targets p50RhoGAP to endosomes and provides a link between Rab and Rho GTPases.	TFRC ARHGAP1	8.32e-05	3	184	2	16380373
Pubmed	Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology.	ERCC2 PARP1	8.32e-05	3	184	2	19109787
Interaction	TOP3B interactions	PLXNA3 TEAD2 ERCC2 NDOR1 MYO10 INPPL1 MED14 SLCO4A1 POMGNT1 FYCO1 HUWE1 NCLN SLC29A2 MAP3K5 BAP1 ZCCHC14 LATS2 POMGNT2 CELSR2 MTOR KLHL21 NISCH TTLL4 CSPG4 TMEM132A PKD1 PRKACA PCYT2 MMS19 CAMSAP1 DYNC1H1 EVI5L	2.54e-06	1470	181	32	int:TOP3B
Interaction	RHOH interactions	SLC12A6 SLC4A7 WWP2 SLCO4A1 NCLN SLC7A11 ZAP70 TFRC ARHGAP1 VPS13D MTOR NT5DC2 NISCH PRKACA PRKCI MMS19 ITM2C	3.94e-06	512	181	17	int:RHOH
Interaction	RAC1 interactions	PCYT1A SLC4A7 GIT1 WWP2 INPPL1 DUSP2 TMEM138 SLCO4A1 HUWE1 NCLN SLC7A11 DENND4C BAP1 TFRC ARHGAP1 MTOR FDFT1 NISCH PRKACA SGCE PRKCI MMS19 NME1 PLXNB1 AMIGO2	1.00e-05	1063	181	25	int:RAC1
Interaction	RYK interactions	TFRC PARP1 CELSR2 CSPG4 TIMM50 DCHS1 SGCE ITM2C PCDH18 DYNC1H1	2.27e-05	212	181	10	int:RYK
Interaction	TUBB2A interactions	KCTD9 MYO10 RABAC1 HUWE1 BAP1 UBE2O LATS2 PRKACA CNTNAP2 LRP1 PRKCI DYNC1H1	3.01e-05	316	181	12	int:TUBB2A
Interaction	LOC254896 interactions	ADGRV1 CELSR2 NISCH CSPG4 DCHS1	4.04e-05	43	181	5	int:LOC254896
Interaction	GPR156 interactions	ZNF627 SLC4A7 FARP2 ACAD11 PRKCI THAP12	4.26e-05	71	181	6	int:GPR156
GeneFamily	O-linked N-acetylglucosaminyltransferases\|Tetratricopeptide repeat domain containing	POMGNT1 POMGNT2	2.60e-04	4	120	2	446
ToppCell	COVID-19-kidney-PCT-S3-2\|kidney / Disease (COVID-19 only), tissue and cell type	MAT1A CP GC BHMT GYS2 HSD17B6 C8B ABCG5	6.67e-07	174	184	8	5aa2fb631505600f37d2b87b02def7be139dc262
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A GBE1 CP GLDC GYS2 HSD17B6 SERPIND1 ABCG5	6.97e-07	175	184	8	5c38d4b6c03473d841e6203a7efaa6dcb2d59386
ToppCell	COVID-19-kidney-PCT-S3-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAT1A CP GC BHMT GYS2 HSD17B6 C8B ABCG5	7.27e-07	176	184	8	b6497324e3e52f514ce556a3fa0c3011c45dcc7b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC4A7 SLCO4A1 ADGRV1 LRP1B DENND4C LMO7 SGCE CSGALNACT1	1.24e-06	189	184	8	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	TEX14 TFRC PLXDC2 AOC3 LRP1 SLC49A3 C8B AMIGO2	1.29e-06	190	184	8	4cce4ddb79b7751d0103e10f71156977e0c34439
ToppCell	remission-Plasmablast\|remission / disease stage, cell group and cell class	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.40e-06	192	184	8	4bcf22061905177ad8625b87be2fbca9bff03ec6
ToppCell	PBMC-Convalescent-Lymphocyte-B-Plasmablast\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.45e-06	193	184	8	239f2ac64f63d4d65997ba83b932a1fab1909efb
ToppCell	PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.45e-06	193	184	8	94daa8a5d23558998fe3bff585344e22ce679f2d
ToppCell	PBMC-Convalescent-Lymphocyte-B-Plasmablast\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.45e-06	193	184	8	33dad901e0597f0057edc2bfbd64fd81f298b94e
ToppCell	PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.45e-06	193	184	8	902dea0bf6c2997d8b877ae01113460e511a364a
ToppCell	PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.45e-06	193	184	8	2790b245d6052063c207087b91fb9375a0e8055d
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A7 MYO10 HUWE1 KCNB1 NISCH PRKCB MGA DYNC1H1	1.57e-06	195	184	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	ASK452-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SLC12A6 KCTD9 RARRES2 TIMM50 SGCE MMS19 KLHL18 WDR44	1.57e-06	195	184	8	20f492299a684ac1b7dd1bbc36a533cd6f9a1c93
ToppCell	COVID-19_Convalescent-Lymphoid_P\|COVID-19_Convalescent / Disease group, lineage and cell class	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.57e-06	195	184	8	4fff177aa4617060b594e637885cd0c91e7d6609
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RARRES2 SVEP1 PPP1R3C PLXDC2 CNTNAP2 LRP1 PRKCB ITM2C	1.57e-06	195	184	8	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	COVID-19_Convalescent-Lymphoid_P-Plasmablast\|COVID-19_Convalescent / Disease group, lineage and cell class	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.57e-06	195	184	8	b4cfc31e4f7e899c6b2578b1ea4fbf609b7ae914
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RARRES2 CP SVEP1 PLXDC2 SAMD11 LRP1 SGCE PCDH18	1.76e-06	198	184	8	0f4052a59c6bd89dab637d6ef1214460d6cbcf55
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-B-Plasmablast\|COVID-19_Convalescent / Disease, condition lineage and cell class	RABAC1 PKHD1L1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.83e-06	199	184	8	7bd4a07c4d0843921a99d5c6df6eb55e62f1ba0e
ToppCell	medial-mesenchymal-Pericyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 MYO10 NT5DC2 CSPG4 AOC3 SGCE ITM2C PCDH18	1.90e-06	200	184	8	bbda454260016be92b539e220ecf7bcbbc6139e4
ToppCell	medial-mesenchymal-Pericyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 MYO10 NT5DC2 CSPG4 AOC3 SGCE ITM2C PCDH18	1.90e-06	200	184	8	f36d7cb6345daccebf76997f998e35d959b59452
ToppCell	wk_20-22-Mesenchymal-Fibroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RARRES2 SVEP1 PPP1R3C PLXDC2 AOC3 LRP1 SGCE ITM2C	1.90e-06	200	184	8	94bd00fb6ff0dcb668eb36ec2085f1c3128855b6
ToppCell	distal-2-mesenchymal-Pericyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 MYO10 NT5DC2 CSPG4 AOC3 SGCE ITM2C PCDH18	1.90e-06	200	184	8	4ee0b2f56c2652435fa78bf6b3c90cea28df74e0
ToppCell	background-Hepatocytes\|background / Sample and Cell Type and Tumor Cluster (all cells)	RARRES2 MAT1A CP GC GYS2 HSD17B6 C8B SERPIND1	1.90e-06	200	184	8	787d35b5c2f2ad967ae14e99496a0299ac7e72fd
ToppCell	distal-mesenchymal-Pericyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 MYO10 NT5DC2 CSPG4 AOC3 SGCE ITM2C PCDH18	1.90e-06	200	184	8	fe31287cfb51d45643bdedbaa5efc03ed87263c6
ToppCell	medial-2-mesenchymal-Pericyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 MYO10 NT5DC2 CSPG4 AOC3 SGCE ITM2C PCDH18	1.90e-06	200	184	8	9820fb4f6efcdfc6de937ef2302a98b48426baa3
ToppCell	droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT PPP1R3C C8B	3.21e-06	151	184	7	e243b6c76e59035f10519a86399b598dd2123f87
ToppCell	droplet-Liver-nan-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT PPP1R3C SERPIND1	3.21e-06	151	184	7	7758cfbe8dca849c90bd6e8bc63310e53beeb8fd
ToppCell	droplet-Liver-Hepatocytes-24m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT PPP1R3C C8B	3.21e-06	151	184	7	cdd2ce0969da446616627e3569bbe5a5d9b475bd
ToppCell	droplet-Liver-nan-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT PPP1R3C SERPIND1	3.21e-06	151	184	7	b4a0546c1573b4b2290890307f2a5daf3a7cbb37
ToppCell	droplet-Liver-nan-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT PPP1R3C SERPIND1	3.35e-06	152	184	7	faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1
ToppCell	droplet-Liver-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT PPP1R3C SERPIND1	3.35e-06	152	184	7	1febeeb7376e34b9f86c81b2cb1314ee12408864
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CAPN3 SLCO4A1 CCDC92 ARHGAP1 POMGNT2 RASSF4 AMIGO2	4.51e-06	159	184	7	7c2f70a7cba880115ccd676fb6c5f18488a5b74f
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 LRP1B PKHD1L1 DSCAML1 SVEP1 CNTNAP2 DNAH9	4.70e-06	160	184	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 LRP1B PKHD1L1 DSCAML1 SVEP1 CNTNAP2 DNAH9	4.70e-06	160	184	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	ADGRV1 LRP1B MAP3K5 VPS13D KCNB1 SAMD11 RASSF4	4.90e-06	161	184	7	347edb0de10850b7d16c40945751033289289c9b
ToppCell	droplet-Liver-Hepatocytes-21m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A GC BHMT PPP1R3C ACAD11 GLDC SERPIND1	5.53e-06	164	184	7	c9866a289e120be4066e66275c3beb97ba67cca4
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A GBE1 CP FDFT1 PCYT2 PNPLA7 SERPIND1	5.75e-06	165	184	7	d449a568664a81d9b5538e8f409301448a32ac37
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DENND4C TFRC LRP1 C8B RASSF4 KLHL18 AMIGO2	7.55e-06	172	184	7	c8ea80042faf923b08ff03d73100533d521d73ef
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	CP PHYHD1 ADGRV1 LMO7 HSD17B6 ELAPOR1 PRKCI	8.77e-06	176	184	7	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM12B CP SDR42E1 SLC6A2 PLXDC2 GLDC CSPG4	9.80e-06	179	184	7	e880c507f11ce75d104593a4ca29f0295f8125e8
ToppCell	COPD-Myeloid-Macrophage_Alveolar\|World / Disease state, Lineage and Cell class	DENND4C TFRC PLXDC2 AOC3 LRP1 C8B AMIGO2	1.17e-05	184	184	7	7fd0b227c3750ffb80e41e92c60fcce46656be14
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A GC VWDE ELAPOR1 SGCE C8B SERPIND1	1.26e-05	186	184	7	4bb54043f944a979db91bde9a86dd66f498c7658
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 SVEP1 PPP1R3C PLXDC2 CNTNAP2 AOC3 PRKCB	1.39e-05	189	184	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	INPP5D APOBEC3A CSGALNACT2 PLXDC2 PRKCB SSH2 MX2	1.39e-05	189	184	7	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FAM234A SLC4A7 MON1B MAP3K5 MFSD14B ZC3H12D SLC49A3	1.44e-05	190	184	7	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	LPS-IL1RA-Endothelial-Epi-like-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RRP1B ZSWIM1 DSCAML1 PHKG1 GLDC PLXNB1	1.48e-05	127	184	6	6b24630978eb0772b4cd3bf59e5bc4390be47619
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RARRES2 CP SVEP1 PPP1R3C PLXDC2 NT5DC2 LRP1	1.49e-05	191	184	7	a05e9a7eb137d804570dd7d8905975d735738767
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	AMN MON1B SGK3 ARHGAP1 DUSP26 NFIC DYNC1H1	1.49e-05	191	184	7	cadb7a9de16f4bb21606de0e25cddd2d748c7f0b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RABAC1 PKHD1L1 PARP1 NT5DC2 ITM2C NME1 GMPPA	1.54e-05	192	184	7	ec279980602292fc8ed6362edd36a5c772d59777
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC7A11 PPP1R3C PHKG1 SFXN5 GLDC PNPLA7 PLXNB1	1.54e-05	192	184	7	261211a86e6f63b09c2ddce1d2d9257d311f1770
ToppCell	remission-Plasmablast\|World / disease stage, cell group and cell class	RABAC1 PARP1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.60e-05	193	184	7	d62617c72863642f2222f7ed28bc6b90ee09b4e0
ToppCell	severe-Plasmablast\|World / disease stage, cell group and cell class	RABAC1 PKHD1L1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.65e-05	194	184	7	49e8f90db571a89b8a26aef31fcacd66429fed11
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 SVEP1 PPP1R3C PLXDC2 CNTNAP2 AOC3 PRKCB	1.65e-05	194	184	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	RARRES2 SVEP1 PPP1R3C PLXDC2 CSPG4 AOC3 PCDH18	1.65e-05	194	184	7	8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3
ToppCell	21-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	RARRES2 PPP1R3C PLXDC2 SAMD11 CSPG4 AOC3 PCDH18	1.65e-05	194	184	7	749dd8113ef260e00facac09de9861d61725124a
ToppCell	severe-Lymphocytic-Plasmablast\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RABAC1 PKHD1L1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.71e-05	195	184	7	43ff1eed563c647bc5b7b06ffe136210653c3a83
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A7 HUWE1 KCNB1 NISCH PRKCB MGA DYNC1H1	1.71e-05	195	184	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	severe-Plasmablast\|severe / disease stage, cell group and cell class	RABAC1 PKHD1L1 GLDC NT5DC2 ITM2C NME1 GMPPA	1.71e-05	195	184	7	e11616ad568e50e4c720b50b0c071f484c31d16b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RARRES2 SVEP1 PPP1R3C PLXDC2 CNTNAP2 LRP1 PRKCB	1.76e-05	196	184	7	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TEAD2 RARRES2 SVEP1 PPP1R3C SAMD11 CNTNAP2 PCDH18	1.76e-05	196	184	7	57df2a57b35be9851ac0b1e5731baa53052511f0
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RARRES2 MYO10 PPP1R3C PLXDC2 CNTNAP2 LRP1 PRKCB	1.82e-05	197	184	7	31a1852911bda38543916585fda34255fd62a134
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RARRES2 SVEP1 PPP1R3C PLXDC2 CNTNAP2 LRP1 PRKCB	1.82e-05	197	184	7	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO10 LRP1B SVEP1 PPP1R3C PLXDC2 CNTNAP2 PRKCB	1.82e-05	197	184	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RARRES2 SVEP1 PPP1R3C PLXDC2 CNTNAP2 LRP1 PRKCB	1.88e-05	198	184	7	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	RARRES2 SVEP1 PPP1R3C PLXDC2 CNTNAP2 PRKCB ITM2C	1.94e-05	199	184	7	f9e3fb974ba8fe1b6d99892577549ef143df9e08
ToppCell	background\|World / Sample and Cell Type and Tumor Cluster (all cells)	RARRES2 MAT1A CP GC GYS2 HSD17B6 C8B	1.94e-05	199	184	7	5a6d0e00bfe1351eea192b54020bedeef78854e9
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	RARRES2 PPP1R3C PLXDC2 AOC3 LRP1 PRKCB ITM2C	1.94e-05	199	184	7	6bce8e65859a35cfea1c210f9c9765952d492ed2
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEAD2 SLCO4A1 LRP1B PKHD1L1 EML5 CNTNAP2	2.01e-05	134	184	6	8707210b2a5d33baa1d204e9e2ed8921181cb309
ToppCell	background-Hepatocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	RARRES2 MAT1A CP GC GYS2 HSD17B6 C8B	2.01e-05	200	184	7	423cca10df6ae0489a8fe7e7df87e70364dac022
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PHYHD1 ADGRV1 SLC7A11 LRP1B PPP1R3C SFXN5 HSD17B6	2.01e-05	200	184	7	7a8160e6477708f22e48c609bf8f43f3715dcb03
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WWP2 LRP1B DSCAML1 PPP1R3C PLXDC2 CSPG4 CSGALNACT1	2.01e-05	200	184	7	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADGRV1 SLC7A11 LRP1B PPP1R3C SFXN5 HSD17B6 PLXNB1	2.01e-05	200	184	7	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	wk_20-22-Mesenchymal\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RARRES2 PPP1R3C PLXDC2 AOC3 LRP1 SGCE ITM2C	2.01e-05	200	184	7	5c8557d2c414d8a8c518270f8c045b53cae45fb6
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WWP2 LRP1B DSCAML1 PPP1R3C PLXDC2 CSPG4 CSGALNACT1	2.01e-05	200	184	7	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RARRES2 MYO10 PPP1R3C PLXDC2 AOC3 LRP1 ITM2C	2.01e-05	200	184	7	0ed49c2177b58269ff7653db6be7d68633a5d34a
ToppCell	distal-3-mesenchymal-Airway_Smooth_Muscle\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 PPP1R3C DUSP26 NT5DC2 AOC3 SGCE ITM2C	2.01e-05	200	184	7	4072cfb3047954f507289587b4bfaf1526936992
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 PPP1R3C DUSP26 NT5DC2 AOC3 SGCE ITM2C	2.01e-05	200	184	7	bc969a956f62570419a5faaf0ab0fd17b343c5ca
ToppCell	distal-mesenchymal-Pericyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 MYO10 CSPG4 AOC3 SGCE ITM2C PCDH18	2.01e-05	200	184	7	867935701fac71a3fe01578362da0676f959736c
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RARRES2 PPP1R3C DUSP26 NT5DC2 AOC3 SGCE ITM2C	2.01e-05	200	184	7	1b5ac5b3ddd4df32e940531cc020998f8cd95c2c
ToppCell	wk_15-18-Mesenchymal-Fibroblast\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	RARRES2 SVEP1 PPP1R3C PLXDC2 CNTNAP2 LRP1 ITM2C	2.01e-05	200	184	7	4f624c3c57d1a84baa86d0830cb1b83ae110bf67
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADGRV1 SLC7A11 LRP1B PPP1R3C SFXN5 HSD17B6 PLXNB1	2.01e-05	200	184	7	cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A ACAD11 HSD17B6 C8B SERPIND1 ABCG5	2.47e-05	139	184	6	4ddfbc36a0560fb70594627178bff652ab1ea3e9
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A ACAD11 HSD17B6 C8B SERPIND1 ABCG5	2.47e-05	139	184	6	82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A ACAD11 HSD17B6 C8B SERPIND1 ABCG5	2.47e-05	139	184	6	fc9ac09c2106e88104a52575832d71d17765eec8
ToppCell	facs-Liver-Hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A ACAD11 HSD17B6 C8B SERPIND1 ABCG5	2.47e-05	139	184	6	fc4b39ac9a10cf0acacfebbc4295edf324d930d5
ToppCell	facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A CELSR2 TGM7 C8B DNAH9 MX2	2.67e-05	141	184	6	4aa4b3476dc5abefbd348353cfe711cd5fe3d52f
ToppCell	facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A CELSR2 TGM7 C8B DNAH9 MX2	2.67e-05	141	184	6	e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZC3H12D PRKCB CATSPERB ITM2C PNPLA7 OTOG	3.01e-05	144	184	6	013223bb2f31eb5bebdbd0908b797d28b96c6f7b
ToppCell	droplet-Liver-Npc-18m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A SDR42E1 GC BHMT PNPLA7	3.51e-05	148	184	6	4ccf87f3e0d2c61148285979ae92cd41778fa321
ToppCell	droplet-Liver-Npc-18m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A SDR42E1 GC BHMT PNPLA7	3.51e-05	148	184	6	981e205cc8a6f6d2a35dc95c5a93ed9193a236b9
ToppCell	droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP BHMT PPP1R3C SERPIND1	3.93e-05	151	184	6	cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYO10 SLC7A11 PPP1R3C PHKG1 GLDC PNPLA7	4.23e-05	153	184	6	95b28c5bd10ffb74c0993ebd565038b9818e4bd2
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYO10 SLC7A11 PPP1R3C PHKG1 GLDC PNPLA7	4.23e-05	153	184	6	3ab9d55b3db51715c1d61eca142384195ce4b54f
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYO10 SLC7A11 PPP1R3C PHKG1 GLDC PNPLA7	4.23e-05	153	184	6	b09f8def40a1ea56722f3398f61a036667b61cd9
ToppCell	facs-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT1A ACAD11 GLDC C8B SERPIND1 ABCG5	4.71e-05	156	184	6	e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell	droplet-Liver-nan-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT PPP1R3C	4.88e-05	157	184	6	b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5
ToppCell	Club_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CP ZSWIM1 SAMD11 NT5DC2 TMEM132A ELAPOR1	5.24e-05	159	184	6	a7bcff268b1962a561fd2848e01ae16565bce895
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARRES2 MAT1A CP GC BHMT FDFT1	5.62e-05	161	184	6	274838cebdc7af1db32d309dfe42ef7ccd3c190b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	INPP5D FYCO1 PLXDC2 MTOR MGA PLXNB1	5.81e-05	162	184	6	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDR42E1 SLC7A11 LRP1B LRP1 PCYT2 PCYT1B	6.02e-05	163	184	6	360cd65decda24853124f33a174f5224d7f3ce23
Drug	Ro-31-8425	ZAP70 HSD17B6 PRKACA PRKACB PRKCB PRKCI THAP12	4.84e-07	60	181	7	CID000002404
Drug	glycogen	PCYT1A INPPL1 CAPN3 GBE1 ADGRV1 GFPT1 PPP1R3C PHKG1 MTOR TTLL4 GYS2 PRKACA PRKACB AOC3 ACP4 PCYT1B	5.50e-07	443	181	16	CID000439177
Drug	sodium	SLC12A6 SLC4A7 WWP2 SLCO4A1 CP GC HUWE1 SLC29A2 SLC7A11 GFPT1 SGK3 SLC5A4 SLC6A2 KCNB1 MTOR KCNJ5 PKD1 PRKACA CNTNAP2 PRKACB PRKCB PRKCI SERPIND1	1.85e-06	944	181	23	CID000000923
Drug	bisindolylmaleimide V	MTOR GYS2 PRKCB PRKCI THAP12	2.55e-06	28	181	5	CID000002400
Drug	rapamycin; Down 200; 0.1uM; MCF7; HG-U133A	AMN MED14 CP VPS13D NFATC3 NFIC KCNJ5 CNTNAP2 C8B DNAH9	4.20e-06	197	181	10	326_DN
Drug	K 252	PCYT1A PRKACA PRKACB PRKCB PRKCI THAP12 PCYT1B	6.59e-06	88	181	7	CID000003813
Disease	Congenital myasthenic syndrome	MYO9A DOK7 GFPT1	2.60e-05	10	180	3	cv:C0751882
Disease	Usher syndrome type 2C (implicated_via_orthology)	SLC4A7 ADGRV1	3.70e-05	2	180	2	DOID:0110839 (implicated_via_orthology)
Disease	Muscular Dystrophies, Limb-Girdle	DOK7 CAPN3 POMGNT1 POMGNT2	4.21e-05	32	180	4	C0686353
Disease	very low density lipoprotein cholesterol measurement	CAPN3 GC CCDC92 DSCAML1 CELSR2 FDFT1 CSGALNACT1 ABCG5	2.07e-04	260	180	8	EFO_0008317
Disease	autosomal dominant polycystic kidney disease (is_implicated_in)	MTOR PKD1	2.20e-04	4	180	2	DOID:898 (is_implicated_in)
Disease	Adrenal Cortical Adenoma	KCNJ5 PRKACB	2.20e-04	4	180	2	C0206667
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	PGS1 CAPN3 CCDC92 CELSR2 FDFT1 CSGALNACT1 ABCG5 MTMR9	2.29e-04	264	180	8	EFO_0008317, EFO_0020944
Disease	Iron Metabolism Disorders	CP TFRC	3.66e-04	5	180	2	C0012715
Disease	Intrahepatic Cholangiocarcinoma	BAP1 PRKACA PRKACB	4.11e-04	24	180	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	BAP1 PRKACA PRKACB	4.11e-04	24	180	3	C3805278
Disease	brain ischemia (biomarker_via_orthology)	CP GC CSPG4 PRKACA PRKACB	4.13e-04	102	180	5	DOID:2316 (biomarker_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	CAPN3 GC CCDC92 CELSR2 FDFT1 CSGALNACT1 ABCG5	4.23e-04	220	180	7	EFO_0004529, EFO_0008317
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	PGS1 STAG1 CAPN3 CELSR2 CSGALNACT1 ABCG5 MTMR9	4.83e-04	225	180	7	EFO_0008317, EFO_0020947
Disease	Cholangiocarcinoma	BAP1 PRKACA PRKACB	5.23e-04	26	180	3	C0206698
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	CAPN3 CCDC92 CELSR2 FDFT1 TGM7 CSGALNACT1 ABCG5	5.37e-04	229	180	7	EFO_0004639, EFO_0008317
Disease	Bare Lymphocyte Syndrome	ZAP70 TFRC	5.46e-04	6	180	2	C0242583
Disease	extraversion	GBE1 MTMR9	5.46e-04	6	180	2	EFO_0004317
Disease	triglyceride measurement, intermediate density lipoprotein measurement	CAPN3 CCDC92 CELSR2 FDFT1 CSGALNACT1	6.08e-04	111	180	5	EFO_0004530, EFO_0008595
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	PGS1 CAPN3 CELSR2 FDFT1 CSGALNACT1 ABCG5 MTMR9	6.91e-04	239	180	7	EFO_0008317, EFO_0020945
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	PGS1 STAG1 CAPN3 CCDC92 CELSR2 FDFT1 CSGALNACT1	7.62e-04	243	180	7	EFO_0004612, EFO_0020944
Disease	perinatal necrotizing enterocolitis (is_marker_for)	MAP3K5 PARP1	7.62e-04	7	180	2	DOID:8677 (is_marker_for)
Disease	apolipoprotein B measurement	PGS1 ERCC2 STAG1 DOK7 CYP20A1 CCDC92 FARP2 CELSR2 NISCH ELAPOR1 C8B ABCG5	8.12e-04	663	180	12	EFO_0004615
Disease	melanoma	ERCC2 CP LRP1B MAP3K5 BAP1 PARP1 MX2	8.58e-04	248	180	7	C0025202
Disease	Diabetes Mellitus	CP MAP3K5 AOC3	9.72e-04	32	180	3	C0011849
Disease	Pena-Shokeir syndrome type I	DOK7 GBE1	1.01e-03	8	180	2	C1276035
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	DUSP2 APOBEC3A C8B CAMSAP1 PCYT1B	1.28e-03	131	180	5	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	DUSP2 APOBEC3A C8B CAMSAP1 PCYT1B	1.28e-03	131	180	5	C4552091
Disease	Juvenile arthritis	DUSP2 APOBEC3A C8B CAMSAP1 PCYT1B	1.28e-03	131	180	5	C3495559
Disease	Juvenile psoriatic arthritis	DUSP2 APOBEC3A C8B CAMSAP1 PCYT1B	1.28e-03	131	180	5	C3714758
Disease	alcohol use disorder (implicated_via_orthology)	PPP1R3C CLIC1 PRKACA PRKACB PRKCB SSH2	1.29e-03	195	180	6	DOID:1574 (implicated_via_orthology)
Disease	epilepsy (is_implicated_in)	CP KCNB1	1.30e-03	9	180	2	DOID:1826 (is_implicated_in)
Disease	arthritis (is_implicated_in)	GC PARP1	1.30e-03	9	180	2	DOID:848 (is_implicated_in)
Disease	Juvenile-Onset Still Disease	DUSP2 APOBEC3A C8B CAMSAP1 PCYT1B	1.46e-03	135	180	5	C0087031
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	PGS1 CAPN3 CCDC92 CELSR2 FDFT1 CSGALNACT1	1.47e-03	200	180	6	EFO_0004611, EFO_0020945
Disease	abdominal aortic calcification measurement	PLXDC2 SEC62	1.61e-03	10	180	2	EFO_0010272
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	PGS1 STAG1 CAPN3 CCDC92 FDFT1 CSGALNACT1	1.71e-03	206	180	6	EFO_0004612, EFO_0020947
Disease	Parkinson Disease	CP RPL14 MAP3K5 CNTNAP2	1.85e-03	85	180	4	C0030567
Disease	ovary epithelial cancer (is_implicated_in)	ERCC2 NME1	1.96e-03	11	180	2	DOID:2152 (is_implicated_in)
Disease	migraine disorder, fasting blood glucose measurement	FAM234A PPP1R3C	1.96e-03	11	180	2	EFO_0004465, MONDO_0005277
Disease	triglyceride measurement, phospholipid measurement	PGS1 CAPN3 CCDC92 FDFT1 CSGALNACT1	2.06e-03	146	180	5	EFO_0004530, EFO_0004639
Disease	hereditary spastic paraplegia (implicated_via_orthology)	CAPN3 PNPLA7 MX2	2.30e-03	43	180	3	DOID:2476 (implicated_via_orthology)
Disease	N-acetylputrescine measurement	SLC6A2 TUBGCP6	2.35e-03	12	180	2	EFO_0800127
Disease	cholesteryl ester 20:2 measurement	DOK7 THAP12	2.35e-03	12	180	2	EFO_0021440
Disease	nevus count, cutaneous melanoma	ADGRV1 PARP1 NFIC MX2	2.37e-03	91	180	4	EFO_0000389, EFO_0004632
Disease	Diabetes Mellitus, Non-Insulin-Dependent	FAM234A MAT1A INPPL1 CCDC92 BHMT PRKCB	2.43e-03	221	180	6	C0011860
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	PGS1 CAPN3 CELSR2 CSGALNACT1 ABCG5 MTMR9	2.49e-03	222	180	6	EFO_0008317, EFO_0020943
Disease	Malignant neoplasm of breast	MED14 APOBEC3A BAP1 TFRC SGK3 ZCCHC14 PARP1 SEMA5B CLIC1 MTOR NISCH ELAPOR1 DNAH9 PLXNB1 PADI3	2.52e-03	1074	180	15	C0006142
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	PGS1 CAPN3 CCDC92 CELSR2 FDFT1 CSGALNACT1	2.60e-03	224	180	6	EFO_0004530, EFO_0008317
Disease	putamen volume change measurement	CNTNAP2 DCHS1	2.76e-03	13	180	2	EFO_0021495
Disease	Skin Abnormalities	ERCC2 FDFT1	2.76e-03	13	180	2	C0037268
Disease	Liver Cirrhosis, Experimental	INPP5D INPPL1 SDR42E1 GC PPP1R3C CLIC1 SAMD11 HSD17B6 PRKCB RASSF4 CSGALNACT1 ABCG5	2.95e-03	774	180	12	C0023893
Disease	Primary Ciliary Dyskinesia	DNAAF11 DNAAF2 DNAH9	2.97e-03	47	180	3	C4551720
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	PGS1 CCDC92 CELSR2 FDFT1 NISCH CSGALNACT1 ABCG5	3.15e-03	312	180	7	EFO_0004612, EFO_0010351
Disease	Malformations of Cortical Development	MTOR DYNC1H1	3.21e-03	14	180	2	C1955869
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	POMGNT1 POMGNT2	3.21e-03	14	180	2	C1836373
Disease	alpha-Dystroglycanopathies	POMGNT1 POMGNT2	3.21e-03	14	180	2	C2936406
Disease	Fukuyama Type Congenital Muscular Dystrophy	POMGNT1 POMGNT2	3.21e-03	14	180	2	C0410174
Disease	Muscle eye brain disease	POMGNT1 POMGNT2	3.21e-03	14	180	2	C0457133
Disease	Cortical Dysplasia	MTOR DYNC1H1	3.21e-03	14	180	2	C0431380
Disease	Autosomal recessive limb-girdle muscular dystrophy	CAPN3 POMGNT1	3.21e-03	14	180	2	cv:C2931907
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	POMGNT1 POMGNT2	3.21e-03	14	180	2	C4284790
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	PGS1 CCDC92 CELSR2 FDFT1 NISCH CSGALNACT1 ABCG5	3.32e-03	315	180	7	EFO_0004574, EFO_0004612
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	CAPN3 CCDC92 CELSR2 FDFT1 CSGALNACT1	3.58e-03	166	180	5	EFO_0004530, EFO_0004611
Disease	Walker-Warburg congenital muscular dystrophy	POMGNT1 POMGNT2	3.69e-03	15	180	2	C0265221
Disease	platelet storage pool deficiency (implicated_via_orthology)	SLC7A11 HPS1	3.69e-03	15	180	2	DOID:2223 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of bladder	ERCC2 MTOR	3.69e-03	15	180	2	C0496930
Disease	Benign neoplasm of bladder	ERCC2 MTOR	3.69e-03	15	180	2	C0154017
Disease	Carcinoma in situ of bladder	ERCC2 MTOR	3.69e-03	15	180	2	C0154091
Disease	type 2 diabetes mellitus (implicated_via_orthology)	PPP1R3C PARP1 AOC3 PRKCI	3.97e-03	105	180	4	DOID:9352 (implicated_via_orthology)
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	CAPN3 CCDC92 FDFT1 CSGALNACT1	4.10e-03	106	180	4	EFO_0008317, EFO_0008596
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	MTOR PKD1	4.20e-03	16	180	2	DOID:0110861 (implicated_via_orthology)
Disease	Ischemic stroke, fibrinogen measurement	STAG1 CAPN3 GYS2	4.64e-03	55	180	3	EFO_0004623, HP_0002140
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	CAPN3 CCDC92 FDFT1 CSGALNACT1	4.68e-03	110	180	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	CAPN3 CCDC92 FDFT1 CSGALNACT1	4.68e-03	110	180	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	muscular dystrophy (is_implicated_in)	CAPN3 POMGNT1	4.74e-03	17	180	2	DOID:9884 (is_implicated_in)
Disease	Antibody Deficiency Syndrome	ZAP70 C8B	4.74e-03	17	180	2	C0003257
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	CAPN3 FARP2 GYS2	4.88e-03	56	180	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	sphingosine 1-phosphate measurement	MON1B UBE2O	5.31e-03	18	180	2	EFO_0800185
Disease	Carcinoma of bladder	ERCC2 MTOR	5.31e-03	18	180	2	C0699885
Disease	antihyperlipidemic drug use measurement	STAG1 DOK7 GC CELSR2	5.47e-03	115	180	4	EFO_0803367
Disease	fatty acid measurement	STAG1 MYO10 DOK7 CAPN3 DSCAML1 CELSR2 FDFT1 CSGALNACT1	5.50e-03	436	180	8	EFO_0005110
Disease	Congenital Myasthenic Syndromes, Presynaptic	MYO9A GFPT1	5.91e-03	19	180	2	C0751884
Disease	Omenn Syndrome	ZAP70 TFRC	5.91e-03	19	180	2	C2700553
Disease	bilirubin measurement	FAM234A STAG1 INPP5D TFRC PHKG1 MFSD14B GYS2 ITM2C	5.96e-03	442	180	8	EFO_0004570
Disease	apolipoprotein A 1 measurement	PGS1 STAG1 DOK7 PERM1 CCDC92 FARP2 CELSR2 NFATC3 NFIC LRP1 MGA CSGALNACT1	6.05e-03	848	180	12	EFO_0004614

Protein segments in the cluster

Peptide	Gene	Start	Entry
GFEPYHIRAIAEELA	BHMT	301	Q93088
RDIARTYPEHEFFKG	EVI5L	156	Q96CN4
FDAVLFEPSRHAAYI	FAM234A	481	Q9H0X4
GLFVSEDLRYPSRHS	CATSPERB	261	Q9H7T0
RRGDFIYVDIFEGHL	CSPG4	246	Q6UVK1
HRPYTASDFIEGIYR	CSGALNACT1	201	Q8TDX6
FYGRHAELRFLDLVP	APOBEC3A	66	P31941
EPDVQRGRSFHFYDA	GSDMD	71	P57764
HVADPTAYGIYIVDR	GYS2	541	P54840
NIGFSPYFVITHEER	ADGRV1	3316	Q8WXG9
EAFHFVSYVPITGRL	BAP1	166	Q92560
DDAIYSVHVPAGLYR	GIT1	541	Q9Y2X7
YVFHNGSLVIESPRF	AMIGO2	341	Q86SJ2
VVLLTHGPAFDLERY	AMN	256	Q9BXJ7
YVSDIRRFLSAFHEP	DFFB	81	O76075
EYRLAGVGHDFPFTI	CELSR2	541	Q9HCU4
AHPVVFSRYIGEEES	CAMSAP1	756	Q5T5Y3
FERIAGEASRLPHYN	H2BC12L	71	P57053
FRFTSEVPIRLDYHG	ATG2B	1811	Q96BY7
IIRPLSVFGYTDNFH	ACAD11	581	Q709F0
DTVFHPSGAIEIRFY	AOC3	476	Q16853
RIISEHFLVEDSYFP	CHM	426	P24386
ILDFFHGYRIIPDSV	RBM12B	941	Q8IXT5
LRVQRAGEDPHSFYF	RARRES2	136	Q99969
RVEDGPSEFALYIVH	RASSF4	211	Q9H2L5
PSEFALYIVHESGER	RASSF4	216	Q9H2L5
DLSNRFYTLIPHDFG	PARP1	731	P09874
PLPAADAAHEFTVYR	NCLN	36	Q969V3
FGIRHSDYLAPLVTD	ODF3B	236	A8MYP8
DPSNGAIYALRIFDH	PCDH18	521	Q9HCL0
LRYSVPEEAKHGTFV	PCDHA2	31	Q9Y5H9
VDRPFLFLIYEHRTS	SERPIND1	471	P05546
HRFTPVLTLEKGFYE	KCNJ5	331	P48544
HFPRGAARSYDLSDI	LRCH4	56	O75427
HVFVLSEAGKPIYSR	MON1B	111	Q7L1V2
KHRGVYSSDVFDIFP	CP	1006	P00450
VPFDYEHTESFRLLV	DCHS1	2771	Q96JQ0
DHRGAFLIDRSPEYF	KCTD9	131	Q7L273
IGRFSEPHARFYAAQ	PRKACA	136	P17612
PEEHARFYSAEISLA	PRKCI	351	P41743
EIIRGHEYLSHPFAV	LRP1B	1461	Q9NZR2
RKAAHRDPVFYDTLG	MGA	1101	Q8IWI9
GTLFLSPSRHDEIEY	HECA	416	Q9UBI9
VYDVVFHPDALALAR	DNAAF2	141	Q9NVR5
EVFPEHLARFYIAEL	LATS2	761	Q9NRM7
VATFRHGGRFPVLSY	MTMR9	176	Q96QG7
IVHDLISRDYSLGPF	MMS19	196	Q96T76
FYHLTVDRPVIYDGS	FYCO1	1461	Q9BQS8
NYERFVPRGAFIHVD	FUT4	446	P22083
YIADDNEIRSLFPGH	LRP1	3871	Q07954
HLESLGIPDVIFFYR	ELAPOR1	786	Q6UXG2
FGAQPYRHLSDEEVL	LMTK3	346	Q96Q04
NHFEGLFRYKSIPVE	DUSP2	211	Q05923
CLGHPEEFYNLVRFR	FDFT1	6	P37268
PVRVYADGIFDLFHS	PCYT1A	76	P49585
PVRVYADGIFDLFHS	PCYT1B	76	Q9Y5K3
ERPYIIAGLHFDQEV	PCYT2	241	Q99447
RVDGFQDAHLYETVP	PLXNA3	441	P51805
YAERIFFPGHRESPL	PLXNB1	1571	O43157
GPIDFEESRFYEIHA	PCDHGC5	306	Q9Y5F6
GAIPAAYVHIERQFF	PGS1	426	Q32NB8
FFVVPALITARYHRD	CES5A	411	Q6NT32
LEVFQYEHILSFGAP	MYO10	1991	Q9HD67
GVFHANPYVLRAFED	LMO7	521	Q8WWI1
LDEDTVYHLQPSGRF	MAT1A	236	Q00266
RFYEEFDAHGREVPL	ERCC2	156	P18074
DYHVDGPIATVFTRE	TUBGCP3	641	Q96CW5
HREEPYLTEAGRDAF	TUBGCP6	306	Q96RT7
GRFKEPHAVFYAAEI	PRKCB	436	P05771
PHAVFYAAEIAIGLF	PRKCB	441	P05771
FYTLRQFPGLAHEAR	POMGNT2	176	Q8NAT1
SYEVPRLHGDEERFF	PADI3	236	Q9ULW8
HLADGPFAVLVDYIR	HUWE1	3976	Q7Z6Z7
FHGVFEKYPETLVRV	PNPLA7	251	Q6ZV29
HYLDIASVPRRSFFE	NDOR1	301	Q9UHB4
PADIIHDFQRGLTAY	ITM2C	141	Q9NQX7
VPAFHGVVERDGESY	ITPKA	231	P23677
HARLPSFAIPYAIDV	MED14	146	O60244
SHNLREEFIGFLPYE	THAP12	286	O43422
LLAYRLEFTDTFPVH	PLPPR2	31	Q96GM1
SFLTYRFGHDVPRVV	OR52R1	261	Q8NGF1
ALVFRHGDRAPLASY	ACP4	36	Q9BZG2
YHFRDQILAGSPEAF	GMPPA	96	Q96IJ6
DLTEYRHVTLFRPFG	CSGALNACT2	241	Q8N6G5
SEAFEHNGRPYSLLV	GBE1	671	Q04446
IGRFSEPHARFYAAQ	PRKACB	136	P22694
GEFHASSKVFRYDPR	KLHL15	341	Q96M94
DLVHFSVSELPSRGY	KLHL18	11	O94889
DRHPGAFTSILNFYR	KCNB1	86	Q14721
RFYLLAHVEAEPLVA	KLHL21	231	Q9UJP4
HFGVKISIVEPGYFR	HSD17B6	196	O14756
FVYGDPRSLVEFVHV	SDR42E1	211	Q8WUS8
FGSIHVYFGDPVSLR	GNPAT	321	O15228
VSIIPEHRFFITYHG	DSCAML1	166	Q8TD84
SAPLHPEFEEVYRFG	CCDC92	211	Q53HC0
RFIEHFALVLEYAGP	FRMPD3	216	Q5JV73
LLARVPDFYFHTIGQ	BTBD8	76	Q5XKL5
HDRFLLDGAPFRYVS	GLB1L	36	Q6UWU2
FIVGVDSRYFDLHDP	DENND4C	466	Q5VZ89
VARFGYFSAALLAPH	ABCG5	496	Q9H222
ASFDHYREFVVATLP	DNAAF11	126	Q86X45
VGEPTYDAEFQHFLR	DYNC1H1	3896	Q14204
DVINFDGHVVLPYRF	CNTNAP2	186	Q9UHC6
HDIRFSPDSRYLAVG	EML5	1781	Q05BV3
YFHAVVAERRKFGPQ	DNAH9	4056	Q9NYC9
EFLVNLHERYGPVVS	CYP20A1	56	Q6UW02
YALGEVHRFHVTVAP	DOK7	106	Q18PE1
SNIDPIYEFHRGFLR	FARP2	581	O94887
EDFPGLVHFIYVDRT	HPS1	536	Q92902
YEPHQEGEFILRVFS	CAPN3	561	P20807
FLVYIVPRAAIFHSD	SLC12A6	291	Q9UHW9
RSFPEHRARFYAAEI	SGK3	256	Q96BR1
IPEVYEHFFFGEDRL	PERM1	656	Q5SV97
LFTNSFEGPVLDHRY	C8B	181	P07358
GRPSVYHAAIVIFLE	MFSD14B	41	Q5SR56
HQDASFLYTEPLGRV	PHYHD1	156	Q5SRE7
ESLQGADHRPYTFFI	PKD1	2966	P98161
ILQGFSEHPEYRVFL	OR13A1	31	Q8NGR1
EFHSVERKFATIYGP	NAP1L6P	71	A6NFF2
DRHYRTFDGLPFDFV	OTOG	991	Q6ZRI0
YLVEEVRHFSPRGKF	PHKG1	291	Q16816
LDFTDYASRIIHPIV	MTOR	1146	P42345
RQPSLFYHLGVRESF	MAP3K5	161	Q99683
IGRDQELYFFHELSP	TARS1	326	P26639
KFTPAAEFYERGVLH	SLC6A2	206	P23975
RAVYIGVHVPFSKES	SLC4A7	41	Q9Y6M7
PNGVRFHFIDIYLDE	RRP1B	161	Q14684
APRDSYHLVGISFFI	SLC29A2	6	Q14542
FVDVLVDYGSDPNHR	TEX14	71	Q8IWB6
VKSFLGPYDEFQRRH	PPP1R3C	36	Q9UQK1
FSDHTVAPAELYDRR	TMEM132A	686	Q24JP5
FHLAVLRGYDVDFPR	GFPT1	676	Q06210
HYVDLKDRPFFAGLV	NME1	51	P15531
FLPDTEGHTYVAFIR	POMGNT1	566	Q8WZA1
TFDLYPHVVGFLNID	ARHGAP1	331	Q07960
PFYGHFLREITVATG	PLXDC2	166	Q6UX71
LHFEEEEITFAPTYR	INPP5D	631	Q92835
VHTYRILPDGEDFLA	INPPL1	66	O15357
YTPRADSFHIFRDAV	SLC5A4	256	Q9NY91
EASTFEDPQRLYHLG	SAMD11	201	Q96NU1
RELYDRGPPHAFFLV	TEAD2	286	Q15562
EYELPELNTRAFHVG	SNAPC3	31	Q92966
FIEALLPHVRAFAYT	NFIC	16	P08651
SPETAHRLFGDIAFY	SVEP1	2031	Q4LDE5
FVEPDHYVVVGAQRD	TFRC	396	P02786
IRYLGVEAHDSPAFD	DUSP26	111	Q9BV47
YPSAGVLFVHVLERE	SGCE	51	O43556
VFALPHFTAGRYEVE	SLCO4A1	186	Q96BD0
GFTIPEAFRGVHRYL	CLIC1	196	O00299
FFHTPYRRLQAESGE	SLC49A3	441	Q6UXD7
RTAVRLGDPHFYQDS	TMEM138	136	Q9NPI0
FIPGVFSEHLIKRYD	PPP1R17	76	O96001
LFYVASREGHLPEIL	SLC7A11	341	Q9UPY5
YTFTDPHIITFDGRV	VWDE	426	Q8N2E2
PHIITFDGRVYDNFK	VWDE	431	Q8N2E2
AHLPFFYGSISRAEA	ZAP70	6	P43403
DSVDPHGFISYRLFR	TIMM50	206	Q3ZCQ8
SINPDHLTYFRFIGR	WWP2	596	O00308
GLYRDLFHGATFVPR	MRPL38	156	Q96DV4
DVGFIDSFRPLYTHE	SEC62	271	Q99442
TREIDNFFPGVFEYH	SSH2	341	Q76I76
FVEVGRVAYVSFGPH	RPL14	6	P50914
VGYRFVTAIFVLPHE	NISCH	976	Q9Y2I1
SVYDIADHPDFRFRT	UBE2O	641	Q9C0C9
YTFELSRRTHLPEVF	GC	346	P02774
TAIAFHPRDDRYFLS	WDR44	651	Q5JSH3
GKAFDYPSLFRIHER	ZNF627	201	Q7L945
FIGTADDRYLRPHAF	NFATC3	481	Q12968
YSAHRPVAVAAGEFL	STAG1	421	Q8WVM7
SAFHLPEQDLIYGVF	SEMA5B	361	Q9P283
IPLHLFVGRSEATYA	PKHD1L1	1506	Q86WI1
YADALHPEIFSTARD	NT5DC2	81	Q9H857
RAFLIEPEHVNTVGY	VCPIP1	166	Q96JH7
LFGREVSPAHQYALA	RABAC1	121	Q9UI14
FRDRGHTYIKVFVPS	ZC3H12D	121	A2A288
AGPDAFYVERNHVDL	ZCCHC14	161	Q8WYQ9
KRYGHASVFLSPDVI	LCMT2	356	O60294
GHLARAVYFAIPAKE	ZSWIM1	106	Q9BR11
RYVIFGDDHLSAPTD	TRIM64	306	A6NGJ6
SFYGRFRHFLDIIDP	SFXN5	36	Q8TD22
AIREGDVHLAYDTPF	TGM7	381	Q96PF1
GQFERIFPSHISSRY	TTLL4	1021	Q14679
RYVIFGDDHLSAPTD	TRIM64B	306	A6NI03
PAVRHLLGAFAFYLE	TTC22	66	Q5TAA0
FLQRVRTSPEGYAHF	VPS13D	2736	Q5THJ4
RGYVGHEFILDTRPF	GLDC	856	P23378
QTHPYFRVLLEEGSA	MX2	351	P20592
FEDNEHTLRIYPGAI	MYO9A	11	B2RTY4